Nicolas Piuzzi, MD

Appointed
2018

Education & Fellowships

Fellowship - Cleveland Clinic
Orthopedic Regenerative Medicine and Cellular Therapies
Cleveland, OH USA
2018

Residency - Hospital Italiano de Buenos Aires
Orthopedic Surgery
Buenos Aires,
2016

Medical Education - Universidad del Salvador
Buenos Aires,
2010

Additional Training

Professional Highlights

• Associate Professor in the Department of Surgery in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
• Cleveland Clinic Musculoskeletal Research Center (MSRC) Co-Director
• Associate Editor Journal of Knee Surgery
• Associate Editor Journal of Hip Surgery

Certifications

• Orthopaedic Surgery

Awards & Honors

• 2010
  • Honor Graduation – Medical Doctor (GPA: 8.90/10) (3rd highest GPA) UNIVERSIDAD DEL SALVADOR, Buenos Aires, Argentina 2010
  • First place Award - XIV Research meeting Universidad del Salvador for study titled: “Anatomic variations of the popliteal artery and its collaterals”, Buenos Aires Argentina, 2010
  •  2012
    • Accésit Award - XVII Residents Session at the A.A.O.T Orthopedic Argentine Annual meeting Annual Meeting: Awarded for study titled: “Arthroscopic repair of Bankart lesion in athletes”, Buenos Aires, Argentina. December 2-5, 2012
    •  2013
      • Special Mention - Menção especial para o trabalho – Tema Livre Oral – XIX Shoulder and Elbow Latin American meeting. Awarded for study titled: “Non-surgical functional treatment for displaced olecranon fractures in the elderly”, Natal, Brazil. October 24-26, 2013
      • First Place Award POSTER - XIX Congreso de la Asociación del Trauma Ortopedico. [XIX Argentinian Trauma Association Annual meeting]
      • Awarded for study titled:"Penetration in the anterolateral cortical in proximal femur fractures treated with short intramedullary nails: Two Case Report”, Buenos Aires, Argentina. October 17-19, 2013
      • First Place Award Oral Presentation 39th Argentinian Hand Association Annual Meeting – [Asociación Argentina de Cirugía de la Mano. 39 Congreso Argentino de Cirugía de la Mano.] For the study titled: “Non-surgical functional treatment for displaced olecranon fractures in the elderly”, San Luis, Argentina October 13, 2013
      •  2014
        • Annual Award Laboratorio Bagó – for the study titled: “Therapeutic modification of the natural history of osteoarthritis, role of supplements” 51º A.A.O.T.: Orthopedic Argentine Annual meeting - Buenos Aires, Argentina. December 10, 2014
        •  2015
          • First Place Paper Award - Residents Session of the 52º A.A.O.T. Orthopedic Argentine Annual meeting: For study titled: “Clinical and radiological outcomes comparison between total ankle arthroplasty and total ankle arthrodesis for the treatment of posttraumatic ankle osteoarthritis” Buenos Aires, Argentina. December 1-5, 2015
          • AAOS/ORS Biologic Treatments of Orthopaedic Injuries (BTOI) research symposium
          • Selected to participate as a Young Investigator in the symposium November 5-7, 2015, in Rosemont, IL
          •  2016
            • Leading article J Bone Joint Surg Am. 2016 Sep 21;98(18):1511-21: Intra-Articular Cellular Therapy for Osteoarthritis and Focal Cartilage Defects of the Knee: A Systematic Review of the Literature and Study Quality Analysis. (doi: 10.2106/JBJS.15.01495.) Piuzzi NS*, Chahla J,* Mitchell JJ, Dean CS, Pascual-Garrido C, LaPrade RF, Muschler GF. (*First co-authors)
            •  2017
              • Young Entrepreneur Award, AAOS/ORS Translating Orthopaedic Technologies into Clinical Practice: Pathways from Novel Idea to Improvements in Standard of Care Research Symposium, Rosemont, IL, May 2017
              • 2017 recipient of the Best Poster Award in "Complications Not Including Infection" category for the poster entitled “Low-Dose Aspirin has Non-Inferior Chemoprophylactic Effect on Venous Thromboembolism after Total Knee Arthroplasty” and presented at the 2017 AAHKS Annual Meeting in Hilton Anatole Hotel, Dallas, TX, November 2-5, 2017
              • 2017 Blue Ribbon Article Award Winner (November/December 2017) Factors Influencing Patients’ Hospital Rating After Total Joint Arthroplasty by Jaydev B. Mistry, MD; Chukwuweike U. Gwam, MD; Morad Chughtai, MD; Anton Khlopas, MD; Prem Ramkumar, MD; Nicolas S. Piuzzi, MD; George Muschler, MD; Steven F. Harwin, MD; Michael A. Mont, MD; Ronald E. Delanois, MD
              •  2018
              • AAOS Optimizing Clinical Use of Biologics in Orthopaedic Surgery. Selected to participate as a Young Investigator in the symposium February 15-17, 2018, in Stanford, 2018
              • AAOS/OREF/ORS Clinician Scholar Career Development Program Award-Rosemont, IL - September 27-29, 2018
              • 2019
                • Best Poster Award in "Primary Total Hip Arthroplasty" category for the poster entitled “No Clinically Meaningful Difference in 1-Year Patient-Recorded Outcomes Among Major Approaches for primary Total Hip Arthroplasty” and presented at the 2019 AAHKS Annual Meeting in Hilton Anatole Hotel, Dallas, TX, November 2019
                • 2020
                  • OREF/Current Concepts in Joint Replacement (CCJR) Clinical Practice Award: “Developing a Personalized Outcome Prediction Tool for Knee Arthroplasty” Nicolas S. Piuzzi, MD
                  • 2022
                    • ORS Strategies in Clinical Research Section 500 Award in recognition to outstanding quality and scientific achievement at ORS 2022 Annual Meeting to Presentation #217: "Combination of Preoperative PROMs Phenotypes (Pain, Function, and Mental Health) Predicts Outcomes After Total Knee Arthroplasty" Nicolas S. Piuzzi, MD

                    Innovations & Patents

                    • 
                      

                    Memberships

                    • American Academy of Orthopaedic Surgeons (AAOS)
                    • American Association of Hip and Knee Surgeons (AAHKS)
                    • Orthopaedic Research Society (ORS)
                    • International Cartilage Repair Society (ICRS)
                    • International Society for Cellular Therapy (ISCT)
                    • Mid-America Orthopaedic Association
                    • Asociación Argentina de Ortopedia y Traumatologia (AAOT)
                    • American Medical Association
                    • Member of the workgroup for the AAOS Treatment of Osteoarthritis of the Knee Clinical Practice Guideline – 2018/19 - Department of Research, Quality, & Scientific Affairs, American Academy of Orthopaedic Surgeons
                    • Member of the voting panel for the AAOS Surgical Site Infection Appropriate Use Criteria Voting Panel -2018/19 Department of Research, Quality, & Scientific Affairs, American Academy of Orthopaedic Surgeons
                    • Member of the voting panel for the Appropriate Use Criteria for the Management of Osteoarthrosis of the Hip – 2017 - Department of Research, Quality, & Scientific Affairs, American Academy of Orthopaedic Surgeons.www.aaos.org/oahipauc. Published December 8, 2017
                    • Member Task Force - Engaging the Orthopaedic Surgeon Project Team – Orthopaedic Research Society 2017
                    • Member of American Physical Therapy Academy (APTA) Clinical Practice Guideline (CPG) for Total Knee Arthroplasty (TKA): Pre and Post-operative Physical Therapist Management for Adults with Osteoarthritis Work Group – 2017/18
                    • Member of Orthopaedic Clinical Research Committee (CRC) – Orthopaedic Research Society (ORS), 2018-2020
                    • Organizing Committee: Signature Series Event of the International Society for Cellular Therapies: “Cellular Therapies for Orthopaedics and Musculoskeletal disease Proven and Unproven Therapies - Promise, Facts and Fantasy”, Montreal, Canada, May 2, 2018

See publications for Nicolas Piuzzi, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/1/2023, Dr. Piuzzi has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Piuzzi receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Stryker Corporation
• Pacira Pharmaceuticals, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.